Literature DB >> 9731398

Medical and financial aspects of same-day bilateral total knee arthroplasties.

M W Kovacik1, P Singri, S Khanna, I A Gradisar.   

Abstract

In this retrospective study, we compared forty-five patients who had undergone same-day bilateral total knee arthroplasties with 144 patients who had undergone unilateral total knee arthroplasty procedures. All procedures were performed by a single surgeon using a single prosthetic design between June 1994 to May 1996. The issues studied were the length of hospital stay, hospital charges, units of blood transfused, units of homologous blood transfused, and the rate and type of complications. This study also examined the usage and financial charges of extended care facilities and/or home health care following discharge from the hospital. Results show that, for patients suffering from symptomatic bilateral knee disease, the same-day bilateral total knee procedure is significantly less costly than staged bilateral procedures. The rate and type of complications seen in the same-day bilateral cases were not significantly different from complications seen in unilateral cases.

Entities:  

Mesh:

Year:  1997        PMID: 9731398

Source DB:  PubMed          Journal:  Biomed Sci Instrum        ISSN: 0067-8856


  9 in total

1.  Knee awareness and functionality after simultaneous bilateral vs unilateral total knee arthroplasty.

Authors:  Roshan Latifi; Morten Grove Thomsen; Thomas Kallemose; Henrik Husted; Anders Troelsen
Journal:  World J Orthop       Date:  2016-03-18

2.  Simultaneous, same-anaesthetic bilateral total knee arthroplasty has low mortality and complication rates.

Authors:  Eugene Wong; Chu Luan Nguyen; Sean Park; David Parker
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-03-24       Impact factor: 4.342

3.  Perioperative morbidity and mortality of same-day bilateral TKAs: incidence and risk factors.

Authors:  Lazaros Poultsides; Stavros Memtsoudis; Alejandro Gonzalez Della Valle; Ivan De Martino; Huong T Do; Michael Alexiades; Thomas Sculco
Journal:  Clin Orthop Relat Res       Date:  2014-01       Impact factor: 4.176

4.  Perioperative outcomes after unilateral and bilateral total knee arthroplasty.

Authors:  Stavros G Memtsoudis; Yan Ma; Alejandro González Della Valle; Madhu Mazumdar; Licia K Gaber-Baylis; C Ronald MacKenzie; Thomas P Sculco
Journal:  Anesthesiology       Date:  2009-12       Impact factor: 7.892

5.  In-hospital complications and mortality of unilateral, bilateral, and revision TKA: based on an estimate of 4,159,661 discharges.

Authors:  Stavros G Memtsoudis; Alejandro González Della Valle; Melanie C Besculides; Licia Gaber; Thomas P Sculco
Journal:  Clin Orthop Relat Res       Date:  2008-08-14       Impact factor: 4.176

6.  Comparative perioperative outcomes associated with neuraxial versus general anesthesia for simultaneous bilateral total knee arthroplasty.

Authors:  Ottokar Stundner; Ya-Lin Chiu; Xuming Sun; Madhu Mazumdar; Peter Fleischut; Lazaros Poultsides; Peter Gerner; Gerhard Fritsch; Stavros G Memtsoudis
Journal:  Reg Anesth Pain Med       Date:  2012 Nov-Dec       Impact factor: 6.288

7.  Reduction of sample size requirements by bilateral versus unilateral research designs in animal models for cartilage tissue engineering.

Authors:  Patrick Orth; David Zurakowski; Mauro Alini; Magali Cucchiarini; Henning Madry
Journal:  Tissue Eng Part C Methods       Date:  2013-04-25       Impact factor: 3.056

8.  Trends in bilateral total knee arthroplasties: 153,259 discharges between 1990 and 2004.

Authors:  Stavros G Memtsoudis; Melanie C Besculides; Shane Reid; Licia K Gaber-Baylis; Alejandro González Della Valle
Journal:  Clin Orthop Relat Res       Date:  2008-11-11       Impact factor: 4.176

9.  Costs of staged versus simultaneous bilateral total knee arthroplasty: a population-based study of the Taiwanese National Health Insurance Database.

Authors:  Aaron Chih-Chang Lin; En Chao; Che-Ming Yang; Hsyien-Chia Wen; Hsiao-Li Ma; Tzu-Chuan Lu
Journal:  J Orthop Surg Res       Date:  2014-07-15       Impact factor: 2.359

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.